WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback